Prostate Cancer
Recent Abstracts
A comprehensive bone-health management approach for men with prostate cancer receiving androgen deprivation therapy - Abstract
September 20, 2011
Efficacy of alternative antiandrogen therapy for prostate cancer that relapsed after initial maximum androgen blockade - Abstract
September 19, 2011
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody - Abstract
September 19, 2011
Heregulin expression and prognosis in prostate adenocarcinoma - Abstract
September 19, 2011
Dietary acrylamide and risk of prostate cancer - Abstract
September 19, 2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis - Abstract
September 19, 2011
Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: A case report - Abstract
September 19, 2011
Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men - Abstract
September 19, 2011
Circulating and disseminated tumor cells in the management of advanced prostate cancer - Abstract
September 19, 2011
Does the transrectal ultrasound probe influence prostate cancer detection in patients undergoing an extended prostate biopsy scheme? Results of a large retrospective study - Abstract
September 19, 2011
Genetics may explain why calcium increases risk for prostate cancer
September 19, 2011
Prostate cancer can be detected even in patients with decreased PSA less than 2.5 ng/ml after treatment of chronic prostatitis - Abstract
September 16, 2011
Are we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups - Abstract
September 16, 2011
Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: Diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging - Abstract
September 16, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study - Abstract
September 16, 2011
Clinical trial update and novel therapeutic approaches for metastatic prostate cancer - Abstract
September 16, 2011
The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy - Abstract
September 16, 2011
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy - Abstract
September 16, 2011
Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone - Abstract
September 16, 2011
Gleason score 7 prostate cancer on needle biopsy: Relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy - Abstract
September 15, 2011
Page 1336 of 1415
Start
Prev
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free